预防性输尿管支架在宫颈癌根治性子宫切除术中预防医源性输尿管损伤的应用分析
本回顾性研究纳入2018年6月至2023年6月在山东大学齐鲁医院(青岛)行开腹根治性子宫切除术的304例宫颈癌患者,比较支架组(129例)与对照组(175例)的输尿管及膀胱损伤率、输尿管狭窄、泌尿系统并发症和成本效益。结果显示两组输尿管及膀胱损伤发生率无统计学显著差异(P > 0.05);放疗后支架组输尿管狭窄16例(27.1%)、对照组5例(5.6%),两组狭窄患病率有显著差异(P < 0.05);放疗导致的新发输尿管狭窄发生率两组无统计学显著差异(6.5% vs. 2.3%,P > 0.05);支架组泌尿系统并发症发生率有统计学显著差异(P < 0.05),且手术时间、手术费用和住院费用更高。结论认为预防性输尿管支架未减少输尿管损伤或放疗后狭窄,反而增加泌尿系统并发症和医疗费用。
要点
- 支架组与对照组输尿管及膀胱损伤发生率无统计学显著差异(P > 0.05)。
- 放疗后支架组输尿管狭窄16例(27.1%),对照组5例(5.6%),两组患病率有显著差异(P < 0.05)。
- 支架组泌尿系统并发症发生率有统计学显著差异(P < 0.05),且手术时间、手术费用和住院费用更高。
核心结论
- 预防性输尿管支架未减少开腹根治性子宫切除术患者的输尿管损伤,也未预防放疗后输尿管狭窄的发生。
- 相反,使用输尿管支架增加了泌尿系统并发症发生率和医疗费用。
研究设计与样本
- 回顾性研究,纳入2018年6月至2023年6月在山东大学齐鲁医院(青岛)行开腹根治性子宫切除术的304例宫颈癌患者。
- 患者分为输尿管支架组(129例)和对照组(175例)。
主要发现
- 两组输尿管及膀胱损伤发生率无统计学显著差异(P > 0.05)。
- 支架组59例、对照组89例术后接受放疗;放疗结束后支架组输尿管狭窄16例(27.1%),对照组5例(5.6%),两组患病率有显著差异(P < 0.05)。
- 放疗导致的新发输尿管狭窄发生率两组无统计学显著差异(6.5% vs. 2.3%,P > 0.05)。
- 两组泌尿系统并发症发生率有统计学显著差异(P < 0.05)。
- 支架组手术时间、手术费用和住院费用更高,增加了总医疗费用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the use of prophylactic ureteral stent for preventing ureteral injury in patients with cervical cancer undergoing radical hysterectomy. METHODS: This retrospective study included 304 patients with cervical cancer who underwent abdominal radical hysterectomy at Qilu Hospital of Shandong University (Qingdao) from June 2018 to June 2023. Patients were divided into the ureteral stent group (129 cases) and the control group (175 cases). The value of the use of prophylactic ureteral stents was compared between two groups in terms of ureteral and bladder injury rates, ureteral strictures, urinary system complications and cost-effectiveness. RESULTS: There was no statistically significant difference in the incidence of ureteral and bladder injury between the two groups (P > 0.05). Postoperative radiotherapy was given to 59 patients in the stent group and 89 patients in the control group. There were 16 (27.1 %) and 5 (5.6 %) cases of ureteral stricture in the stent and control groups after the end of radiotherapy. The prevalence of ureter stricture in the two groups were significantly different (P < 0.05). There was no statistically significant difference in the incidence of newly emerged ureteral strictures caused by radiotherapy between the two groups (6.5 % vs. 2.3 %, P > 0.05). The incidences of urinary complications were statistically significant between the two groups (P < 0.05). Operation time, surgery cost and hospitalization expenses were higher in the stent group, which increased the total medical cost. CONCLUSION: The use of prophylactic ureteral stent did not reduce the occurrence of ureteral injuries in patients undergoing abdominal radical hysterectomy, nor prevent the incidence of ureteral stricture after radiotherapy. On the contrary, the use of ureteral stent increased the incidence of urinary complications and medical cost.
引用
- Wang Y, Jia Z, Jiao J, et al. Analysis of the use of prophylactic ureteral stents in preventing iatrogenic ureteral injury during radical hysterectomy for cervical Cancer. Gynecol Oncol. 2025. PMID: 40752273. doi:10.1016/j.ygyno.2025.07.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。